三核苷酸重复扩增
基因沉默
亨廷顿蛋白
生物
亨廷顿病
体细胞
亨廷顿蛋白
DNA错配修复
小干扰RNA
癌症研究
聚谷氨酰胺束
遗传学
细胞生物学
基因
分子生物学
DNA修复
核糖核酸
疾病
医学
等位基因
病理
突变体
作者
Daniel O’Reilly,Jillian Belgrad,Chantal M. Ferguson,Ashley Summers,Ellen Sapp,Cassandra A. McHugh,Ella W. Mathews,Adel Boudi,Julianna E. Buchwald,Socheata Ly,Dimas Moreno,Raymond C. Furgal,Eric Luu,Zachary Kennedy,Vignesh Narayan Hariharan,Kathryn R. Monopoli,X William Yang,Jeff A Carroll,Marian DiFiglia,Neil Aronin M. D
标识
DOI:10.1016/j.ymthe.2023.05.006
摘要
Huntington's disease (HD) is a severe neurodegenerative disorder caused by the expansion of the CAG trinucleotide repeat tract in the huntingtin gene. Inheritance of expanded CAG repeats is needed for HD manifestation, but further somatic expansion of the repeat tract in non-dividing cells, particularly striatal neurons, hastens disease onset. Called somatic repeat expansion, this process is mediated by the mismatch repair (MMR) pathway. Among MMR components identified as modifiers of HD onset, MutS homolog 3 (MSH3) has emerged as a potentially safe and effective target for therapeutic intervention. Here, we identify a fully chemically modified short interfering RNA (siRNA) that robustly silences Msh3 in vitro and in vivo. When synthesized in a di-valent scaffold, siRNA-mediated silencing of Msh3 effectively blocked CAG-repeat expansion in the striatum of two HD mouse models without affecting tumor-associated microsatellite instability or mRNA expression of other MMR genes. Our findings establish a promising treatment approach for patients with HD and other repeat expansion diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI